India Approves Further Trials For First Homegrown MRNA Covid Vaccine
[email protected]14 Oct, 2021News
India has approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine developed by Gennova Biopharmaceuticals Ltd, the government said on Tuesday, after the shot was found to be safe and effective in an early-stage study. Gennova is among a few pharmaceutical firms worldwide, including Moderna Inc (MRNA.O) and Pfizer Inc (PFE.N), to use mRNA technology in its coronavirus shot. These vaccines do not use a live virus to generate an immune response but prompt the human body to make a protein that triggers one.
Related Bookmarks
- India Says Homegrown MRNA COVID-19 Shot Safe In Early Trial
- AgustaWestland VVIP Chopper Case: ED Searches Ex-Emmar MGF MD Shravan Gupta's Premises
- Best Burger In Delhi | Online Burger Delivery
- Mcm Monogram Visetos Jacquard Twin Pocket 869448 Black Nylon Backpack
- Henrik Radich Otkj�r - Help organizations develop positive culture in private cabins and homes
- How Do I Access My Dlinkap local?
- Everything You Need To Know About The Larry OG Strain
- Recreational And Medical Benefits Of Bruce Banner Strain
- Best Blocked Drains services in Macclesfield
- Best Internal Plastering Services to Contact in North London
Recent Profiles
E.j. Thompson & Son Llc
Winvn Win Vn Link Đăng Nhập Nhà Cái Winvn.
Uu88 Krd
Abc8
Dall Winther
Hdbet Yachts
Karlsen Hvass
Andreasen Ernst
Howell Bentley
Hassan Dissing